A Bayesian perspective on Biogen's aducanumab trial. Temp AGM, Ly A, van Doorn J, Wagenmakers EJ, et al. Alzheimers Dement 2022;18:2341-2351.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Temp AGM, Ly A, van Doorn J, Wagenmakers EJ, et al. A Bayesian perspective on Biogen's aducanumab trial. Alzheimers Dement 2022;18:2341-2351.
PMID: 35235700